Ketanserin, 97%, a specific 5-HT2A serotonin receptor antagonist

Name: Ketanserin, 97%, a specific 5-HT2A serotonin receptor antagonist | 74050-98-9
Brand: J&K Chemical
SKU: JK283801_50_MG
Price: 20.8 USD
Availability: OutOfStock

Cat. No JK283801_50_MG

Vendor: J&K Chemical

Product Information

Product Name

Ketanserin, 97%, a specific 5-HT2A serotonin receptor antagonist

Brand Name

J&K

Product Number

283801

CAS

74050-98-9

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

3822

IUPAC Name

3-2-4-(4-fluorobenzoyl)piperidin-1-ylethyl-1H-quinazoline-2,4-dione

InChI Key

FPCCSQOGAWCVBH-UHFFFAOYSA-N

SMILES

C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O

Safety Information

Storage Condition

Freezer -20℃

References

The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation

Publication Name: Nature Neuroscience

Publication Date: 2025-08-04

DOI: 10.1038/s41593-025-02021-1

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants

Publication Name: Clinical Pharmacokinetics

Publication Date: 2025-07-14

DOI: 10.1007/s40262-025-01544-x

Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions

Publication Name: Neurochemical Research

Publication Date: 2025-07-11

DOI: 10.1007/s11064-025-04481-0|10.1007/s11064-025-04608-3

Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action

Publication Name: CNS Drugs

Publication Date: 2025-07-10

DOI: 10.1007/s40263-025-01199-z

The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine

Publication Name: Molecular Psychiatry

Publication Date: 2025-07-07

DOI: 10.1038/s41380-025-03100-2

Ketanserin, 97%, a specific 5-HT2A serotonin receptor antagonist

Product Information

General Information

Safety Information

References

The psychoplastogen tabernanthalog induces neuroplasticity without proximate immediate early gene activation

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants

Chronic Combined Oral Methylphenidate and Fluoxetine Increases Inflammation in Somatosensory and Mesolimbic Brain Regions

Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action

The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine